Skip to main content
Clinical Trials/IRCT2017101436753N1
IRCT2017101436753N1RecruitingPhase 3

Evaluation of the effect of furosemide inhalation versus placebo in patients with acute cardiogenic pulmonary edema

Vice chancellor for research, Iran University of Medical Sciences0 sites120 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
no limit to no limit (—)
Sex
All

Inclusion Criteria

  • All the patients with acute cardiogenic edema will be included in the study.
  • Exclusion criteria: not willing to participate in the study, history of susceptibility to sulfa drugs, unstable hemodynamics; requiring mechanical ventilation; decreased consciousness, accompany with another illness requiring treatment in the first 10 minutes of treatment with digoxin, beta blocker, beta-agonist and calcium; need to have another inhaling treatment in the first 10 minutes and need to have non-invasive ventilation.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research, Iran University of Medical Sciences

Similar Trials